Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Mish's Global Economic Trend Analysis -- Ignore unavailable to you. Want to Upgrade?

To: skinowski who wrote (100426)	8/5/2009 8:46:36 PM
From: Elroy Jetson	5 Recommendations Read Replies (1) \| Respond to of 116555

Yes, the unnatural influence large pharmaceutical firms have over American politicians has eliminated normal free market dynamics in the pharmaceutical industry. Only because of the undue influence of large pharma is the government prohibited from seeking competitive bids on pharmaceuticals for Medicare like private insurers do. Only because of this undue influence of large pharma is the retail price for pharmaceuticals nearly triple the price in America as in other nations of the world. Only because of this undue influence of large pharma does the large pharmaceutical industry enjoy a return on capital which is triple that of other American businesses. Americans should demand the restoration of a free market in the pharmaceutical market. This would take unleash the creative potential of smaller pharmaceutical firms which actually create new medications and greatly reduce costs and fraud in medical care. .